Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will earn $5.62 per share for the year, down from ...

San Diego CVS pharmacy workers approved a new contract Friday night that included raises and other benefits.

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, Steve Nelson, a former UnitedHealthcare CEO.

CVS Health will report earnings on Wednesday morning, weeks after dumping its CEO in a desperate effort to reassure investors ...

CVS Health faced mixed results in its latest earnings report, revealing revenue growth amid segment struggles.

CVS Health (CVS) stock gains as company reports better than expected Q3 2024 revenue and names former UnitedHealth (UNH) ...

CVS Health (NYSE:CVS) is scheduled to announce Q3 earnings results on Wednesday, November 6th, before market open. Analysts ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide medical care. In his first earnings call following a ...